Burning Rock Biotech Limited Net Income (Loss) Available to Common Stockholders, Basic
Burning Rock Biotech Limited (BNR) reported Net Income (Loss) Available to Common Stockholders, Basic of -CNY 971.23 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-20.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2023-04-20
CNY
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|
| 2022-12-31 | -971.23M CNY 20-F · filed 2023-04-20 |
| 2021-12-31 | -796.70M CNY 20-F · filed 2023-04-20 |
| 2020-12-31 | -471.92M CNY 20-F · filed 2023-04-20 |
| 2019-12-31 | -334.17M CNY 20-F · filed 2022-04-29 |
| 2018-12-31 | -232.35M CNY 20-F · filed 2021-03-23 |
USD
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|
| 2022-12-31 | -$140.81M 20-F · filed 2023-04-20 |
| 2021-12-31 | -$125.02M 20-F · filed 2022-04-29 |
| 2020-12-31 | -$72.33M 20-F · filed 2021-03-23 |